Anterior chamber–associated immune deviation and its impact on corneal allograft survival
- 1 August 2006
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 11 (4) , 360-365
- https://doi.org/10.1097/01.mot.0000236697.07092.ac
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cellsBritish Journal of Ophthalmology, 2005
- Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune DeviationInvestigative Opthalmology & Visual Science, 2003
- CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent toleranceEuropean Journal of Immunology, 2002
- Evidence for multiple CD95–CD95 ligand interactions in anteriorchamber‐associated immune deviation induced by soluble protein antigenImmunology, 2000
- Anterior chamber inoculation of splenocytes without Fas/Fas‐ligand interaction primes for a delayed‐type hypersensitivity response rather than inducing anterior chamber‐associated immune deviationEuropean Journal of Immunology, 1997
- SHORT COMMUNICATION: Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyesCurrent Eye Research, 1997
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Role of splenic B cells in the immune privilege of the anterior chamber of the eyeEuropean Journal of Immunology, 1995
- Sympathetic neural modulation of the immune systemBrain, Behavior, and Immunity, 1989